Loading...
•
Mar 31, 2021
Corbus Pharmaceuticals Q1 2021 Earnings Report
Reported financial results for Q1 2021 and provided corporate updates.
Key Takeaways
Corbus Pharmaceuticals reported revenue of $648,000 and a net loss of $16.1 million for the first quarter of 2021. The company's cash, cash equivalents, and investments were $125 million as of March 31, 2021, which is expected to fund operations into the first quarter of 2024.
Revenue from awards and licenses was $648,000.
Operating expenses decreased by $15.5 million to $16.1 million.
Net loss was $16.1 million, or a net loss per diluted share of $0.14.
Cash, cash equivalents and investments were $125 million as of March 31, 2021.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...